FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

FOCUS ON RESEARCH Previous Volume 355:2174-2177 November 23, 2006 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Oner, A. F. Related Article by Kandun, I. N. PubMed Citation

There is no question that there will be another influenza pandemic someday. We simply don't know when it will occur or whether it will be caused by the H5N1 avian influenza virus. But given the number of cases of H5N1 influenza that have occurred in humans to date (251 as of late September 2006) and the rate of death of more than 50%, it would be prudent to develop robust plans for dealing with such a pandemic.

The epicenters of both the Asian influenza pandemic of 1957 and the Hong Kong influenza pandemic of 1968 were in Southeast Asia, and . . . [Full Text of this Article]

Source Information

Dr. Webster is a professor and Dr. Govorkova a senior scientist in the Department of Infectious Diseases, Division of Virology, St. Jude Children's Research Hospital, Memphis, TN.

Related Letters:

Human H5N1 Influenza
Goicoechea M., Pawitan J. A., Dudley J. P., Oner A. F., Ceyhan M., Akdeniz H., Kandun I. N., Sedyaningsih E. R., Uyeki T. M., Webster R. G., Govorkova E. A.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:1375-1377, Mar 29, 2007. Correspondence

This article has been cited by other articles:

• Sehgal, R. N. M. (2010). Deforestation and avian infectious diseases. J. Exp. Biol. 213: 955-960 [Abstract] [Full Text]  
• Reed, M. L., Bridges, O. A., Seiler, P., Kim, J.-K., Yen, H.-L., Salomon, R., Govorkova, E. A., Webster, R. G., Russell, C. J. (2010). The pH of Activation of the Hemagglutinin Protein Regulates H5N1 Influenza Virus Pathogenicity and Transmissibility in Ducks. J. Virol. 84: 1527-1535 [Abstract] [Full Text]  
• Khazeni, N., Hutton, D. W., Garber, A. M., Owens, D. K. (2009). Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic. ANN INTERN MED 151: 840-853 [Abstract] [Full Text]  
• Cusick, M. F., Wang, S., Eckels, D. D. (2009). In Vitro Responses to Avian Influenza H5 by Human CD4 T Cells. J. Immunol. 183: 6432-6441 [Abstract] [Full Text]  
• Khazeni, N., Hutton, D. W., Garber, A. M., Owens, D. K. (2009). Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic. ANN INTERN MED 0: 0000605-200912150-00156v1-E-156 [Abstract] [Full Text]  
• Dunham, E. J., Dugan, V. G., Kaser, E. K., Perkins, S. E., Brown, I. H., Holmes, E. C., Taubenberger, J. K. (2009). Different Evolutionary Trajectories of European Avian-Like and Classical Swine H1N1 Influenza A Viruses. J. Virol. 83: 5485-5494 [Abstract] [Full Text]  
• Smee, D. F., Hurst, B. L., Wong, M.-H., Bailey, K. W., Morrey, J. D. (2009). Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice. Antimicrob. Agents Chemother. 53: 2120-2128 [Abstract] [Full Text]  
• Qi, L., Kash, J. C., Dugan, V. G., Wang, R., Jin, G., Cunningham, R. E., Taubenberger, J. K. (2009). Role of Sialic Acid Binding Specificity of the 1918 Influenza Virus Hemagglutinin Protein in Virulence and Pathogenesis for Mice. J. Virol. 83: 3754-3761 [Abstract] [Full Text]  
• Fazekas, G., Martosne-Mendi, R., Jankovics, I., Szilvasy, I., Vajo, Z. (2009). Cross-Reactive Immunity to Clade 2 Strains of Influenza Virus A Subtype H5N1 Induced in Adults and Elderly Patients by Fluval, a Prototype Pandemic Influenza Virus Vaccine Derived by Reverse Genetics, Formulated with a Phosphate Adjuvant, and Directed to Clade 1 Strains. CVI 16: 437-443 [Abstract] [Full Text]  
• Poon, L. L. M., Leung, Y. H. C., Nicholls, J. M., Perera, P.-Y., Lichy, J. H., Yamamoto, M., Waldmann, T. A., Peiris, J. S. M., Perera, L. P. (2009). Vaccinia Virus-Based Multivalent H5N1 Avian Influenza Vaccines Adjuvanted with IL-15 Confer Sterile Cross-Clade Protection in Mice. J. Immunol. 182: 3063-3071 [Abstract] [Full Text]  
• Ilyushina, N. A., Hay, A., Yilmaz, N., Boon, A. C. M., Webster, R. G., Govorkova, E. A. (2008). Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice. Antimicrob. Agents Chemother. 52: 3889-3897 [Abstract] [Full Text]  
• Hars, J., Ruette, S., Benmergui, M., Fouque, C., Fournier, J.-Y., Legouge, A., Cherbonnel, M., Daniel, B., Dupuy, C., Jestin, V. (2008). THE EPIDEMIOLOGY OF THE HIGHLY PATHOGENIC H5N1 AVIAN INFLUENZA IN MUTE SWAN (CYGNUS OLOR) AND OTHER ANATIDAE IN THE DOMBES REGION (FRANCE), 2006. J Wildl Dis 44: 811-823 [Abstract] [Full Text]  
• Kosakovsky Pond, S. L., Poon, A. F.Y., Leigh Brown, A. J., Frost, S. D.W. (2008). A Maximum Likelihood Method for Detecting Directional Evolution in Protein Sequences and Its Application to Influenza A Virus. Mol Biol Evol 25: 1809-1824 [Abstract] [Full Text]  
• Li, F C K, Choi, B C K, Sly, T, Pak, A W P (2008). Finding the real case-fatality rate of H5N1 avian influenza. J. Epidemiol. Community Health 62: 555-559 [Abstract] [Full Text]  
• Nicoll, A (2008). Children, avian influenza H5N1 and preparing for the next pandemic. Arch. Dis. Child. 93: 433-438 [Abstract] [Full Text]  
• Mizgerd, J. P. (2008). Acute Lower Respiratory Tract Infection. NEJM 358: 716-727 [Full Text]  
• Writing Committee of the Second World Health Organ, (2008). Update on Avian Influenza A (H5N1) Virus Infection in Humans. NEJM 358: 261-273 [Full Text]  
• Kaverin, N. V., Rudneva, I. A., Govorkova, E. A., Timofeeva, T. A., Shilov, A. A., Kochergin-Nikitsky, K. S., Krylov, P. S., Webster, R. G. (2007). Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal Antibodies. J. Virol. 81: 12911-12917 [Abstract] [Full Text]  
• Carter, M. J. (2007). A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol 56: 875-883 [Abstract] [Full Text]  
• Taubenberger, J. K., Morens, D. M., Fauci, A. S. (2007). The Next Influenza Pandemic: Can It Be Predicted?. JAMA 297: 2025-2027 [Full Text]  
• Ebrahim, G. J. (2007). Pandemic H5N1 Influenza. J Trop Pediatr 53: 73-75 [Full Text]  
• Janies, D., Hill, A. W., Guralnick, R., Habib, F., Waltari, E., Wheeler, W. C. (2007). Genomic Analysis and Geographic Visualization of the Spread of Avian Influenza (H5N1). Syst Biol 56: 321-329 [Full Text]  
• Goicoechea, M., Pawitan, J. A., Dudley, J. P., Oner, A. F., Ceyhan, M., Akdeniz, H., Kandun, I. N., Sedyaningsih, E. R., Uyeki, T. M., Webster, R. G., Govorkova, E. A. (2007). Human H5N1 Influenza. NEJM 356: 1375-1377 [Full Text]  
• (2006). Bird flu season is back. BMJ 333: 1164-1164 [Full Text]  
• (2006). Avian Flu: Deadly, and Difficult to Diagnose. JWatch General 2006: 1-1 [Full Text]